ImmunoPrecise Antibodies (IPA) Institutional Ownership $0.49 0.00 (-0.24%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$0.49 +0.01 (+1.04%) As of 08:45 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for ImmunoPrecise Antibodies (NASDAQ:IPA)CurrentInstitutional OwnershipPercentage6.70%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$194.92KNumber ofInstitutional Sellers(last 12 months)0 Get IPA Insider Trade Alerts Want to know when executives and insiders are buying or selling ImmunoPrecise Antibodies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IPA Institutional Buying and Selling by Quarter ImmunoPrecise Antibodies Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Ingalls & Snyder LLC1,558,892$996K0.0%+20.3%5.407% 8/9/2024 Renaissance Technologies LLC63,910$65K0.0%+70.0%0.243% 1/29/2024 Ingalls & Snyder LLC1,281,305$2.19M0.1%+24.6%4.868% 11/13/2023 Rathbones Group PLC14,000$26K0.0%N/A0.056% 11/2/2023 Ingalls & Snyder LLC1,028,253$1.88M0.1%-3.0%4.105% 8/2/2023 Bank of Montreal Can208,110$668K0.0%N/A0.831% 5/9/2023 Ingalls & Snyder LLC1,058,035$2.93M0.2%+9.1%4.244% 2/1/2023 Bank of Montreal Can240,980$1.25M0.0%+6.0%0.966% 1/31/2023 Ingalls & Snyder LLC970,147$5.05M0.3%+0.3%3.891% 11/7/2022 Gradient Capital Advisors LLC26,808$107K0.1%+34.0%0.108% Get the Latest News and Ratings for IPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE daily newsletter. 10/21/2022 Ingalls & Snyder LLC967,090$3.86M0.2%+2.9%3.878% 8/12/2022 Ikarian Capital LLC61,433$237K0.0%-20.9%0.247% 8/11/2022 Bank of Montreal Can194,164$801K0.0%+38.2%0.782% 8/10/2022 Cibc World Market Inc.47,427$183K0.0%N/A0.191% 5/9/2022 Ingalls & Snyder LLC932,200$4.79M0.2%+13.6%4.570% 2/11/2022 Ingalls & Snyder LLC820,258$4.40M0.2%+32.0%4.215% 1/31/2022 Gradient Capital Advisors LLC20,000$107K0.0%-7.9%0.103% 1/24/2022 National Bank of Canada FI7,540$40K0.0%N/A0.039% 11/15/2021 Marshall Wace LLP175,514$1.09M0.0%+384.1%0.906% 11/12/2021 Trexquant Investment LP17,852$111K0.0%N/A0.092% 11/12/2021Credit Suisse AG88,829$553K0.0%+130.0%0.459% 10/27/2021 Ingalls & Snyder LLC621,447$3.87M0.2%+3.4%3.212% 8/25/2021 Marshall Wace LLP36,259$218K0.0%+8.5%0.188% 8/16/2021Credit Suisse AG38,623$233K0.0%+15.6%0.200% 8/16/2021 Marshall Wace LLP36,259$218K0.0%+8.5%0.188% 8/13/2021 Renaissance Technologies LLC17,400$105K0.0%N/A0.090% 8/13/2021 AWM Investment Company Inc.398,145$2.40M0.2%-16.7%2.070% 8/12/2021 Dimensional Fund Advisors LP12,538$75K0.0%N/A0.065% 8/12/2021 JPMorgan Chase & Co.68,885$1.29M0.0%+55.4%0.358% 8/12/2021 Bank of Montreal Can45,224$285K0.0%+543.8%0.235% 8/5/2021 Orion Portfolio Solutions LLC14,111$85K0.0%-16.3%0.073% 8/3/2021 Ingalls & Snyder LLC600,810$3.62M0.2%+16.2%3.124% 5/17/2021 Ikarian Capital LLC150,000$1.47M0.0%N/A0.783% 5/14/2021Credit Suisse AG33,423$328K0.0%N/A0.174% 5/13/2021 AWM Investment Company Inc.478,020$4.69M0.5%N/A2.494% 5/12/2021 JPMorgan Chase & Co.44,320$435K0.0%+127.2%0.231% 5/11/2021 Rockefeller Capital Management L.P.3,965$38K0.0%+75.4%0.021% (Data available from 1/1/2016 forward) IPA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IPA shares? During the previous two years, the following institutional investors and hedge funds held shares of ImmunoPrecise Antibodies shares: Ingalls & Snyder LLC ($996K), Bank of Montreal Can ($668K), and Renaissance Technologies LLC ($65K), Rathbones Group PLC ($26K).Learn more on IPA's institutional investors. What percentage of ImmunoPrecise Antibodies stock is owned by institutional investors? 6.70% of ImmunoPrecise Antibodies stock is owned by institutional investors. Learn more on IPA's institutional investor holdings. Which institutional investors have been buying ImmunoPrecise Antibodies stock? The following institutional investors have purchased ImmunoPrecise Antibodies stock in the last 24 months: Ingalls & Snyder LLC ($516.50K), Bank of Montreal Can ($208.11K), Renaissance Technologies LLC ($26.31K), and Rathbones Group PLC ($14K). How much institutional buying is happening at ImmunoPrecise Antibodies? Institutional investors have bought a total of 764,923 shares in the last 24 months. This purchase volume represents approximately $1.27M in transactions. Which ImmunoPrecise Antibodies major shareholders have been selling company stock? The following institutional investors have sold ImmunoPrecise Antibodies stock in the last 24 months: Ingalls & Snyder LLC ($31.80K). How much institutional selling is happening at ImmunoPrecise Antibodies? Institutional investors have sold a total of 31,802 shares in the last 24 months. This volume of shares sold represents approximately $58.20K in transactions. Related Companies Invizyne Technologies Major Shareholders OncoCyte Major Shareholders Adagene Major Shareholders CervoMed Major Shareholders Corbus Pharmaceuticals Major Shareholders TScan Therapeutics Major Shareholders I-Mab Major Shareholders Inozyme Pharma Major Shareholders Caribou Biosciences Major Shareholders Adaptimmune Therapeutics Major Shareholders This page (NASDAQ:IPA) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoPrecise Antibodies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmunoPrecise Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IPA Stock Free IPA Stock Alerts